It is evolved into a new disease monitoring and evaluation method.

摘要

The invention relates to a monitoring method for disease progression or to evaluate the therapeutic effect of a patient with cytokines or Tau alpha CD73, in which the tissue fluid is used as a patient. The invention also relates to a patient in a tissue liquid sample for the determination of CD73 protein.